Concepedia

Publication | Open Access

Telavancin Versus Standard Therapy for Treatment of Complicated Skin and Soft-Tissue Infections Due to Gram-Positive Bacteria

DOIFull Paper Access

174

Citations

14

References

2005

Year

Martín E. Stryjewski, W. O'Riordan, William K. Lau, Francis D. Pien, Lala M. Dunbar, M Vallee, Vance G. Fowler, Vivian H. Chu, Eden Adekola Torimiro Spencer, Steven L. Barriere,
Clinical Infectious Diseases

Abstract

Clinical and microbiological results of this study support the further development of telavancin, especially for treatment of infection due to MRSA.

References

YearCitations

Page 1